Invention Grant
- Patent Title: Pharmaceutical compositions containing a DGAT1 inhibitor
-
Application No.: US15968104Application Date: 2018-05-01
-
Publication No.: US10646446B2Publication Date: 2020-05-12
- Inventor: Hong Wen , Natrajan Kumaraperumal , Richard Nause
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Judith D. Kuntz
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K31/444 ; A61K9/28

Abstract:
The present invention relates to a pharmaceutical composition comprising a) a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, e.g. 1, 2 or 3, surfactants with lubricant properties; c) one or more, e.g. 1, 2 or 3, dry binders with disintegrant properties; d) one or more, e.g. 1, 2 or 3, fillers, and e) one or more, e.g. 1, 2 or 3, disintegrants.
Public/Granted literature
- US20180243222A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR Public/Granted day:2018-08-30
Information query